M.L. Peris
- Venous Thromboembolism Diagnosis and Management
- Central Venous Catheters and Hemodialysis
- Atrial Fibrillation Management and Outcomes
- Diagnosis and Treatment of Venous Diseases
- Blood Coagulation and Thrombosis Mechanisms
- Acute Myocardial Infarction Research
- Acute Ischemic Stroke Management
- Radiation Dose and Imaging
- Lung Cancer Diagnosis and Treatment
- Cardiac tumors and thrombi
- Colorectal Cancer Screening and Detection
- Maternal and fetal healthcare
- Atomic and Subatomic Physics Research
- Peripheral Artery Disease Management
Universidad Cardenal Herrera CEU
2016-2020
Consorcio Hospitalario Provincial de Castellón
2016-2020
Virginia Commonwealth University
2016
Background Transthoracic echocardiography ( TTE ) is often considered for risk stratification of patients with acute pulmonary embolism PE ). We sought to determine the contemporary utilization early (within 72 hours diagnosis) and explored association between findings ‐related mortality. Methods Results Data from RIETE (Registro Informatizado Enfermedad TromboEmbolica) registry, a multicenter registry consecutive , were used (2001–July 2017). generalized linear mixed model predictors...
Current guidelines suggest treating cancer patients with incidental pulmonary embolism comparably to symptomatic embolism. We used the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry compare rate of major bleeding and during course anticoagulation after its discontinuation in As March 2016, 715 had been enrolled RIETE. During anticoagulant therapy (mean 235 days), was higher than (10.1 (95% CI 7.48–13.4) versus 3.17 1.80–5.19) events per 100 patient–years, respectively),...
Background Current guidelines suggest treating cancer patients with incidental pulmonary embolism (PE) similarly to those clinically suspected and confirmed PE. However, the natural history of these presentations has not been thoroughly compared. Methods We used data from RIETE (Registro Informatizado de Enfermedad TromboEmbólica) registry compare 3-month outcomes in active PE versus The primary outcome was 90-day all-cause mortality. Secondary were PE-related mortality, symptomatic...
Plasma nitrite